A

Aprea Therapeutics
D

APRE

1.39000
USD
-0.09
(-5.89%)
مغلق
حجم التداول
3,475
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
8,097,113
أصول ذات صلة الأخبار المقالات

العنوان: Aprea Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.